Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 1993 May 1;291(Pt 3):869–873. doi: 10.1042/bj2910869

Sensitive, hydrosoluble, macromolecular fluorogenic substrates for human immunodeficiency virus 1 proteinase.

F Anjuère 1, M Monsigny 1, Y Lelièvre 1, R Mayer 1
PMCID: PMC1132449  PMID: 8489513

Abstract

Hydrosoluble macromolecular fluorogenic substrates specific for the human immunodeficiency virus 1 (HIV-1) proteinase have been prepared. The fluoresceinyl peptide Ftc-epsilon-Ahx-Ser-Phe-Asn-Phe-Pro-Gln-Ile-Thr-(Gly)n, corresponding to the first cleavage site of HIV-1 gag-pol native precursor was linked to a water-soluble neutral (Lys)n derivative. The epsilon-aminohexanoyl residue (epsilon-Ahx) and the glycyl sequence were added in order to improve the stability of the substrate and the accessibility of the cleavage site to the HIV-1 proteinase respectively. This macro-molecular peptidic-substrate conjugate is significantly more water-soluble than the free peptide itself on a substrate molar concentration basis. The assay is based on the quantitative precipitation of the polymeric material by adding propan-2-ol whereas the fluorescent peptide moiety released upon proteolysis remains soluble in the supernatant. The proteinase activity is assessed by measuring the fluorescence of the supernatant. This assay allows the detection of a few fmol of HIV-1 proteinase, even in the presence of cell culture media, plasma or cell lysate and it gives accurate results within a large proteinase concentration range. The hydrosoluble macromolecular substrate is also suitable for determining the HIV-1 proteinase activity using 96-well microplates, allowing us to test accurately and rapidly numerous enzyme samples and/or the potency of new proteinase inhibitors.

Full text

PDF
869

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anjuère F., Monsigny M., Mayer R. Water-soluble macromolecular fluorogenic substrates for assaying proteinases: determination of pancreatic elastase activity. Anal Biochem. 1991 Nov 1;198(2):342–346. doi: 10.1016/0003-2697(91)90436-w. [DOI] [PubMed] [Google Scholar]
  2. Cha S. Tight-binding inhibitors-I. Kinetic behavior. Biochem Pharmacol. 1975 Dec 1;24(23):2177–2185. doi: 10.1016/0006-2952(75)90050-7. [DOI] [PubMed] [Google Scholar]
  3. Darke P. L., Nutt R. F., Brady S. F., Garsky V. M., Ciccarone T. M., Leu C. T., Lumma P. K., Freidinger R. M., Veber D. F., Sigal I. S. HIV-1 protease specificity of peptide cleavage is sufficient for processing of gag and pol polyproteins. Biochem Biophys Res Commun. 1988 Oct 14;156(1):297–303. doi: 10.1016/s0006-291x(88)80839-8. [DOI] [PubMed] [Google Scholar]
  4. Derrien D., Midoux P., Petit C., Nègre E., Mayer R., Monsigny M., Roche A. C. Muramyl dipeptide bound to poly-L-lysine substituted with mannose and gluconoyl residues as macrophage activators. Glycoconj J. 1989;6(2):241–255. doi: 10.1007/BF01050652. [DOI] [PubMed] [Google Scholar]
  5. Geohegan K. F., Spencer R. W., Danley D. E., Contillo L. G., Jr, Andrews G. C. Fluorescence-based continuous assay for the aspartyl protease of human immunodeficiency virus-1. FEBS Lett. 1990 Mar 12;262(1):119–122. doi: 10.1016/0014-5793(90)80168-i. [DOI] [PubMed] [Google Scholar]
  6. Hyland L. J., Dayton B. D., Moore M. L., Shu A. Y., Heys J. R., Meek T. D. A radiometric assay for HIV-1 protease. Anal Biochem. 1990 Aug 1;188(2):408–415. doi: 10.1016/0003-2697(90)90628-m. [DOI] [PubMed] [Google Scholar]
  7. Katoh I., Yasunaga T., Ikawa Y., Yoshinaka Y. Inhibition of retroviral protease activity by an aspartyl proteinase inhibitor. Nature. 1987 Oct 15;329(6140):654–656. doi: 10.1038/329654a0. [DOI] [PubMed] [Google Scholar]
  8. Kohl N. E., Emini E. A., Schleif W. A., Davis L. J., Heimbach J. C., Dixon R. A., Scolnick E. M., Sigal I. S. Active human immunodeficiency virus protease is required for viral infectivity. Proc Natl Acad Sci U S A. 1988 Jul;85(13):4686–4690. doi: 10.1073/pnas.85.13.4686. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Leis J., Baltimore D., Bishop J. M., Coffin J., Fleissner E., Goff S. P., Oroszlan S., Robinson H., Skalka A. M., Temin H. M. Standardized and simplified nomenclature for proteins common to all retroviruses. J Virol. 1988 May;62(5):1808–1809. doi: 10.1128/jvi.62.5.1808-1809.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. MCKINNEY R. M., SPILLANE J. T., PEARCE G. W. FLUORESCEIN DIACETATE AS A REFERENCE COLOR STANDARD IN FLUORESCENT ANTIBODY STUDIES. Anal Biochem. 1964 Dec;9:474–476. doi: 10.1016/0003-2697(64)90208-8. [DOI] [PubMed] [Google Scholar]
  11. Matayoshi E. D., Wang G. T., Krafft G. A., Erickson J. Novel fluorogenic substrates for assaying retroviral proteases by resonance energy transfer. Science. 1990 Feb 23;247(4945):954–958. doi: 10.1126/science.2106161. [DOI] [PubMed] [Google Scholar]
  12. Monsigny M., Kieda C., Maillet T. Assay for proteolytic activity using a new fluorogenic substrate (peptidyl-3-amino-9-ethyl-carbazole); quantitative determination of lipopolysaccharide at the level of one picogram. EMBO J. 1982;1(3):303–306. doi: 10.1002/j.1460-2075.1982.tb01164.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Moore M. L., Bryan W. M., Fakhoury S. A., Magaard V. W., Huffman W. F., Dayton B. D., Meek T. D., Hyland L., Dreyer G. B., Metcalf B. W. Peptide substrates and inhibitors of the HIV-1 protease. Biochem Biophys Res Commun. 1989 Mar 15;159(2):420–425. doi: 10.1016/0006-291x(89)90008-9. [DOI] [PubMed] [Google Scholar]
  14. Nashed N. T., Louis J. M., Sayer J. M., Wondrak E. M., Mora P. T., Oroszlan S., Jerina D. M. Continuous spectrophotometric assay for retroviral proteases of HIV-1 and AMV. Biochem Biophys Res Commun. 1989 Sep 15;163(2):1079–1085. doi: 10.1016/0006-291x(89)92331-0. [DOI] [PubMed] [Google Scholar]
  15. Richards A. D., Phylip L. H., Farmerie W. G., Scarborough P. E., Alvarez A., Dunn B. M., Hirel P. H., Konvalinka J., Strop P., Pavlickova L. Sensitive, soluble chromogenic substrates for HIV-1 proteinase. J Biol Chem. 1990 May 15;265(14):7733–7736. [PubMed] [Google Scholar]
  16. Schechter I., Berger A. On the size of the active site in proteases. I. Papain. Biochem Biophys Res Commun. 1967 Apr 20;27(2):157–162. doi: 10.1016/s0006-291x(67)80055-x. [DOI] [PubMed] [Google Scholar]
  17. Tamburini P. P., Dreyer R. N., Hansen J., Letsinger J., Elting J., Gore-Willse A., Dally R., Hanko R., Osterman D., Kamarck M. E. A fluorometric assay for HIV-protease activity using high-performance liquid chromatography. Anal Biochem. 1990 May 1;186(2):363–368. doi: 10.1016/0003-2697(90)90095-q. [DOI] [PubMed] [Google Scholar]
  18. Tomasselli A. G., Olsen M. K., Hui J. O., Staples D. J., Sawyer T. K., Heinrikson R. L., Tomich C. S. Substrate analogue inhibition and active site titration of purified recombinant HIV-1 protease. Biochemistry. 1990 Jan 9;29(1):264–269. doi: 10.1021/bi00453a036. [DOI] [PubMed] [Google Scholar]
  19. Tomaszek T. A., Jr, Magaard V. W., Bryan H. G., Moore M. L., Meek T. D. Chromophoric peptide substrates for the spectrophotometric assay of HIV-1 protease. Biochem Biophys Res Commun. 1990 Apr 16;168(1):274–280. doi: 10.1016/0006-291x(90)91704-v. [DOI] [PubMed] [Google Scholar]
  20. Zimmerman M., Yurewicz E., Patel G. A new fluorogenic substrate for chymotrypsin. Anal Biochem. 1976 Jan;70(1):258–262. doi: 10.1016/s0003-2697(76)80066-8. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES